S-1 · resale registration
Issued 2026
Proposed maximum
Shares registered
- Filed
- Effective
NXTS$0.5416+1.92%
Nexentis Technologies Inc.
Sector: Pharmaceutical PreparationsIndustry: Agricultural InputsCountry: ILExchange: Nasdaq
Mkt Cap:$1.31M
Float & O/S:
Inst Own:
DilutionScan read 36 of Nexentis Technologies Inc.'s SEC filings and found 6 warrant series, 1 convertible, 2 equity lines, 1 shelf registration, 2 S-1 registrations and 3 completed offerings on file for NXTS. The latest dilution event on file is a registration statement on Jul 17, 2026. Analysis updated Oct 19, 2026.
Signal8 Summary
NXTS
Zero revenue and short cash runway
Snapshot
N2OFF is a distressed micro-cap that generated zero revenue in FY 2025 while reporting a net loss of $4.0M. The company burns cash at a rate of $3.8M per year, which gives it a cash runway of roughly seven months.
What's Happening Right Now
- : Nexentis announced an AI drug discovery initiative between its subsidiary MitoCareX Bio and Boltz PBC to combine their technologies for virtual screening.
- : MitoCareX Bio generated an optimized hit molecule with improved pharmaceutical properties, marking its first drug discovery milestone since acquisition.
- : The company received U.S. trademark registration for its MITOLINE algorithm platform used for 3D modeling of mitochondrial proteins.
Raise routes on file: effective shelf + effective S-1 · latest dilution event 109 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jul 17, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2026
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Pre-funded warrants (aggregate, outstanding as of July 10, 2026)
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Equity line
Issued 2023
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
Equity line
Issued 2023
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Registered direct offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Registered direct offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your NXTS trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
